Hydralazinhydrochlorid

Hydralazine hydrochloride Struktur
304-20-1
CAS-Nr.
304-20-1
Bezeichnung:
Hydralazinhydrochlorid
Englisch Name:
Hydralazine hydrochloride
Synonyma:
Apulon;Lopres;Asozart;Hyperex;Lopress;apresine;Dralzine;HSDB 434;Rolazine;Hyperazin
CBNumber:
CB5113442
Summenformel:
C8H9ClN4
Molgewicht:
196.64
MOL-Datei:
304-20-1.mol

Hydralazinhydrochlorid Eigenschaften

Schmelzpunkt:
273°C
Siedepunkt:
322.13°C (rough estimate)
Dichte
1.2961 (rough estimate)
Brechungsindex
1.6110 (estimate)
storage temp. 
2-8°C
Löslichkeit
Soluble in water, slightly soluble in ethanol (96 per cent), very slightly soluble in methylene chloride
Farbe
White to Almost white
PH
pH (20g/l, 25℃) : 3.5~4.5
Wasserlöslichkeit
Soluble in water. Slightly soluble in diethyl ether and alcohol.
Merck 
14,4763
BRN 
3568329
BCS Class
3
Stabilität:
Stable. Incompatible with strong oxidizing agents.
InChIKey
ZUXNZUWOTSUBMN-UHFFFAOYSA-N
CAS Datenbank
304-20-1(CAS DataBase Reference)
EPA chemische Informationen
1(2H)-Phthalazinone, hydrazone, monohydrochloride (304-20-1)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher Xn
R-Sätze: 22-36/37/38
S-Sätze: 26-36/37/39-45
RIDADR  UN 2811 6.1/PG 3
WGK Germany  3
RTECS-Nr. TH9000000
TSCA  Yes
HazardClass  6.1
PackingGroup  III
HS Code  29339900
Giftige Stoffe Daten 304-20-1(Hazardous Substances Data)
Toxizität LD50 oral in rat: 280mg/kg
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H301 Giftig bei Verschlucken. Akute Toxizität oral Kategorie 3 Achtung GHS hazard pictogramssrc="/GHS06.jpg" width="20" height="20" /> P264, P270, P301+P310, P321, P330,P405, P501
H315 Verursacht Hautreizungen. Hautreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P302+P352, P321,P332+P313, P362
H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P305+P351+P338,P337+P313P
H335 Kann die Atemwege reizen. Spezifische Zielorgan-Toxizität (einmalige Exposition) Kategorie 3 (Atemwegsreizung) Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" />
Sicherheit
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.

Hydralazinhydrochlorid Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R22:Gesundheitsschädlich beim Verschlucken.
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.

S-Sätze Betriebsanweisung:

S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36/37/39:Bei der Arbeit geeignete Schutzkleidung,Schutzhandschuhe und Schutzbrille/Gesichtsschutz tragen.
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn möglich, dieses Etikett vorzeigen).

Beschreibung

Hydralazine is an orally bioavailable vasodilator and antihypertensive agent. It decreases DNA methylation in Jurkat cells at a concentration of 10 μM and inhibits extracellular and intracellular production of reactive oxygen species (ROS) in rat macrophages activated by phorbol 12-myristate 13-acetate (PMA; ) at a concentration of 100 μM. Hydralazine (100 μM) also decreases nitric oxide production and mRNA expression of inducible nitric oxide synthase (iNOS) in rat macrophages activated by LPS (Item Nos. 19660| 19661| 19662) and interferon-γ (IFN-γ). It reduces contraction of rat aortic arterial strips induced by potassium and norepinephrine (; IC50s = 2.2 and 3.06 mM, respectively). Hydralazine (2.6 mg/kg) lowers mean arterial blood pressure (MAP) by 41.76% in conscious rats. Formulations containing hydralazine have been used in the treatment of high blood pressure and heart failure.

Chemische Eigenschaften

White Crystalline Solid

Verwenden

Hydralazine hydrochloride has been used:
  • as a vasodilator to study its effects on hypertension in T-cell frequencies in juvenile rats
  • as a semicarbazide-sensitive amine oxidase (SSAO) inhibitor to study its effects on myocardial ischemia-reperfusion (I/R) injury
  • as a vasodilator to study its effects on insulin secretion and glucose tolerance

Definition

ChEBI: The hydrochloride salt of hydralazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Allgemeine Beschreibung

Hydralazine hydrochloride,1-hydrazinophthalazine monohydrochloride(Apresoline hydrochloride), originated from the work of achemist attempting to produce some unusual chemicalcompounds and from the observation that this compoundhad antihypertensive properties. It occurs as yellow crystalsand is soluble in water to the extent of about 3%. A 2%aqueous solution has a pH of 3.5 to 4.5.

Kontakt-Allergie

Hydralazine is a hydrazine derivative used as a antihypertensive drug. Skin rashes have been described during treatment. Exposure occurs mainly in the pharmaceutical industry. Cross-sensitivity is frequent with hydrazine, which is considered to be a potent sensitizer.

Mechanism of action

The only drug in this group, hydralazine, does not fit neatly into the other mechanistic classes, in part because its mechanism of action is not entirely clear. It appears to have multiple, direct effects on the VSM. Hydralazine, a phthalazine-substituted hydrazine antihypertensive drug with a pKa of 7.3, is highly specific for arterial vessels, producing its vasodilation by a couple of different mechanisms. First, it causes smooth muscle hyperpolarization, quite likely through the opening of K+ channels. Activation therefore increases the efflux of potassium ions from the cells, causing hyperpolarization of VSM cells and, thus, prolonging the opening of the potassium channel and sustaining a greater vasodilation on arterioles than on veins. It also may inhibit the second messenger, IP3-induced release of calcium from the smooth muscle sarcoplasmic reticulum (the PIP2 signal transduction pathway). Finally, hydralazine stimulates the formation of NO by the vascular endothelium, leading to cGMP-mediated vasodilation. The arterial vasodilator action of hydralazine reduces systemic vascular resistance and arterial pressure. Diastolic blood pressure usually is decreased more than systolic pressure is. The hydralazine-induced decrease in blood pressure and peripheral resistance causes a reflex response, which is accompanied by increased heart rate, cardiac output, stroke volume, and an increase in plasma renin activity. It has no direct effect on the heart. This reflex response could offset the hypotensive effect of arteriolar dilation, limiting its antihypertensive effectiveness. Hydralazine also causes sodium and water retention and expansion of plasma volume, which could develop tolerance to its antihypertensive effect during prolonged therapy. Thus, coadministration of a diuretic improves the therapeutic outcome.

Clinical Use

Hydralazine hydrochloride is useful in the treatment ofmoderate-to-severe hypertension. It is often used in conjunctionwith less potent antihypertensive agents, becauseside effects occur frequently when it is used alone in adequatedoses. In combinations, it can be used in lower andsafer doses. Its action appears to be centered on the smoothmuscle of the vascular walls, with a decrease in peripheralresistance to blood flow. This results in increased bloodflow through the peripheral blood vessels. It also has theunique property of increasing renal blood flow, an importantconsideration in patients with renal insufficiency.Hydralazine hydrochloride acts on vascular smooth muscleto cause relaxation. Its mechanism of action is unclear. Itinterferes with Ca2+ entry andCa2+release from intracellularstores and reportedly causes activation of guanylate cyclase,resulting in increased levels of cGMP. All of thesebiochemical events can cause vasodilation.

Arzneimittelwechselwirkung

The coadministration of diuretics and other hypotensive drugs may have a synergistic effect, resulting in a marked decrease in blood pressure.

läuterung methode

It crystallises from MeOH and has m 172-173o(dec). [Druey et al. Helv Chim Acta 34 195 1951, Beilstein 25 III/IV 4552.] It is an antihypertensive.

Hydralazinhydrochlorid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Hydralazinhydrochlorid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 355)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hebei Mojin Biotechnology Co., Ltd
+8613288715578
sales@hbmojin.com China 12456 58
Anhui Ruihan Technology Co., Ltd
+8617756083858
daisy@anhuiruihan.com China 994 58
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806
sales@capotchem.com China 29797 60
Hangzhou FandaChem Co.,Ltd.
008657128800458; +8615858145714
fandachem@gmail.com China 9348 55
Hefei TNJ Chemical Industry Co.,Ltd.
+86-0551-65418679 +86-18949832763
info@tnjchem.com China 2989 55
Shanghai Zheyan Biotech Co., Ltd.
18017610038
zheyansh@163.com CHINA 3620 58
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
Jinan Jianfeng Chemical Co., Ltd
0531-88110457; +8615562555968
info@pharmachemm.com China 222 58
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28180 58
Hebei Guanlang Biotechnology Co., Ltd.
+86-19930503282
alice@crovellbio.com China 8823 58

304-20-1(Hydralazinhydrochlorid)Verwandte Suche:


  • 1(2h)-phthalazinone,hydrazone,monohydrochloride
  • 1-hydrazinophthalazinemonohydrochloride
  • 1-hydrazino-phthalazinmonohydrochloride
  • aiselazine
  • apresine
  • apresoline-esidrix
  • Asozart
  • Hydrapress
  • Pressfall
  • Hyperazin
  • Phthalazin-1-ylhydrazine hydrochloride
  • 1-hydrazino-phthalazinmonohydrochlor
  • 1(2H)-Phthalazinone, hydrazone, hydrochloride
  • Dralzine
  • Hydralazine hydrochloride,1-Hydrazinophthalazine hydrochloride
  • Hydralazine Hydrochloride (200 mg)
  • Hydralazine Hydrochloride (200 mg)K1E1830.998mg/mg(dr)
  • 1-Hydrazinylphthalazine Hydrochloride
  • Apulon
  • Lopres
  • Hydralazine HCl/Hydralazine Hydrochloride
  • Hydralazine Hydrochloride, CP
  • Phthalazine,1-hydrazinyl-, hydrochloride (1:1)
  • Apresoline (TN)
  • HSDB 434
  • Hydralazine hydrochloride (JP15/USP)
  • Hydrallazine hydrochloride
  • Hyperex
  • Lopress
  • Phthalazine, 1-hydrazino-, monohydrochloride
  • Phthalazinone, hydrazone, monohydrochloride
  • Rolazine
  • Slow-Apresolin
  • 1-hydrazinyl-phthalazine, hydrochloride (1:1)
  • apresolinehydrochloride
  • hydralazinechloride
  • hydralazinemonohydrochloride
  • nor-press25
  • praparat5968
  • HydralazineHclC8H8N4.HC1
  • Hydrolazine
  • HYDRALAZINEHYDROCHLORIDE,USP
  • 1-HYDRAZINOPHTHALAZINEHCL
  • HYDRAZINOPHTHALAZINEHYDROCHLORIDE
  • (Z)-1-Hydrazono-1,2-dihydrophthalazine hydrochloride
  • MONO-HYDRAZINOPHTHALAZINE HCL
  • HYDRALAZINE HYDROCHLORIDE
  • 1-HYDRAZINOPHTHALAZINE HYDROCHLORIDE
  • 1-PHTHALAZINYLHYDRAZINE HYDROCHLORIDE
  • 1-Hydrazinophthalazine hydrochloride, 99%, a direct-acting vasodilator
  • 1-Hydrazinophthalazine hydrochloride, 99%, direct-acting vasodilator
  • azine hydrochL
  • 8aH-phthalazin-1-one hydrazone hydrochloride
  • Hydralazine hydrochloride CRS
  • 1-HydrazinophthalazineHydrochloride>
  • 1-hydrazinyl-Phthalazine hydrochloride,>98%
  • Hydralazine hydrochloride USP/EP/BP
  • Hydralazinhydrochlorid
Copyright 2019 © ChemicalBook. All rights reserved